Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Nov 10, 2022
- Accession no.
- 0001209191-22-056322
- Filed
- Nov 10, 2022, 6:56 AM ET
- Trade date
- Nov 9, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions. Open-market purchases total $319.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +8,688 | $1.57 | +$13,596.72 | 198,340,382 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +35,100 | $1.57 | +$55,107 | 198,375,482 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +6,300 | $1.58 | +$9,922.5 | 198,381,782 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +20,900 | $1.58 | +$33,001.1 | 198,402,682 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +22,800 | $1.58 | +$36,024 | 198,425,482 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +2,700 | $1.59 | +$4,279.5 | 198,428,182 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +3,512 | $1.59 | +$5,584.08 | 198,431,694 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +2,755 | $1.60 | +$4,394.23 | 198,434,449 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +2,048 | $1.60 | +$3,274.75 | 198,436,497 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +45,197 | $1.60 | +$72,315.2 | 198,481,694 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +11,500 | $1.64 | +$18,802.5 | 198,493,194 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +4,000 | $1.64 | +$6,553.6 | 198,497,194 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +11,573 | $1.64 | +$18,968.15 | 198,508,767 | Indirect | |
| Nov 9, 2022 | Common Stock | PPurchaseAcquired | +22,927 | $1.64 | +$37,600.28 | 198,531,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.